Biosimilars Made Simple: A Micro-Analysis Of Biosimilars & Relevant Policy

With all the promise biosimilars hold, why we are not seeing increased market uptake? There are many reasons that involve policy, legislation, and the legal system that have led to the current state of the biosimilar market in the U.S. Our white paper examines the basics. We like to thank Biosimilar Development for featuring our new analysis!